alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 89, Number 199 (Tuesday, October 15, 2024)]
[Notices]
[Page 83017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23651]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-1262]


Notice of Approval of Product Under Voucher: Rare Pediatric 
Disease Priority Review Voucher; KISQALI (ribociclib)

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
issuance of approval of a product redeeming a priority review voucher. 
The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to 
award priority review vouchers to sponsors of approved rare pediatric 
disease product applications that meet certain criteria. FDA is 
required to publish notice of the issuance of priority review vouchers 
as well as the approval of products redeeming a priority review 
voucher. FDA has determined that the supplemental application for 
KISQALI (ribociclib), approved September 17, 2024, meets the criteria 
for redeeming a priority review voucher.

FOR FURTHER INFORMATION CONTACT: Cathryn Lee, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-1394, email: 
<a href="/cdn-cgi/l/email-protection#c380a2b7abb1baaded8fa6a683a5a7a2edababb0eda4acb5"><span class="__cf_email__" data-cfemail="a8ebc9dcc0dad1c686e4cdcde8ceccc986c0c0db86cfc7de">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: FDA is announcing the approval of a product 
redeeming a rare pediatric disease priority review voucher. Under 
section 529 of the FD&C Act (21 U.S.C. 360ff), FDA will report the 
issuance of rare pediatric disease priority review vouchers and the 
approval of products for which a voucher was redeemed. FDA has 
determined that the supplemental application (Supplement-18) for 
KISQALI (ribociclib) meets the redemption criteria.
    For further information about the Rare Pediatric Disease Priority 
Review Voucher Program and for a link to the full text of section 529 
of the FD&C Act, go to https://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/RarePediatricDiseasePriorityVoucherProgram/default.htm. For further 
information about KISQALI (ribociclib), go to the ``Drugs@FDA'' website 
at https://www.accessdata.fda.gov/scripts/cder/daf/.

    Dated: October 8, 2024.
Eric Flamm,
Acting Associate Commissioner for Policy.
[FR Doc. 2024-23651 Filed 10-11-24; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pane lunani m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l ar g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T B E N IT O P E R E Z L O P E Z ; M A R IA RE M EDI OS RODRI GU EZ , P et i t i o n ers, v. E R I C H . H O L D E R , J r ., A tto rn e yG e n e r a l, R e s p o n d e n t. N o. 10- 71170 A ge nc yN os . A 079- 535- 327

A 079- 535- 673 ME MOR AN DU M *

O n P e t i t i on f

orR e vi e w of

an O r de rof

the B o ar do f I m m ig r a tio n A p p e a ls S ubm i tt e d A pr i l17, 2012 ** B efo re: L E A V Y , P A E Z , an dB E A , C i rcu i tJu d g es. B e ni t o P e r e z L ope z and M ar i aR e m e di os R odr i gue z , na t i ve s and c i t i z e ns of M exi co, pet i t i on pro se f or re vi ew of the B oard of Im m i grat i on A pp ea l s’ (“ B IA ”) o r d e rd e n y in g th e irm o tio n to r e o p e n b a s e do n in e f f e c tiv e a s s is tan c e o f

c o u n s e l. 

# FI LED APR19 2 012 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALSW e have j ur i s di c t i on unde r8 U . S . C . § 1252. W e r e vi e w f orabus e of

di s c r e t i on the d e n ia l o f am o tio n to r e o p e n , an dr e v ie w d e n o v o c la im s o f du e p r o c e s s v io la tio n s . Moh am m ed v. G on zales , 400 F . 3d 785, 791- 92 ( 9th C i r . 2005) . W e de nythe p e t i t i o n f o rr e v i e w. T h e B I A d idn o t ab u s e its d is c r e tio n in d e n y in g p e titio n e r s ’ m o tio n to r e ope n a s unt i m e l ybe c aus e the m ot i on w a s f i l e d m or e than tw o y e ar s a f t e rthe f in a l o r d e ro f

r e m o v a l, se e 8 C .F .R . § 1 0 0 3 .2 ( c ) ( 2 ) , an dp e titio n e r s f a ile dto e s tab lis h th e du e d ilig e n c e r e qu ir e df o re qu itab le to llin g o f

th e f ilin g d e a d lin e , se e I tu rr i b a rr i a v . I

NS , 32 1 F . 3d88 9, 89 7 (9th C i r. 20 03 ). I n l i ghtof

ourdi s pos i t i on, w e ne e d notr e a c h pe t i t i one r s ’ r e m a i ni ng co n t en t i o n s. P E T I T I ON F OR RE V I E W DE NI E D.
#                                                     Mariam  Kiran                                            

### 

## Contact

kiranm@ornl.gov|865.341.2910

## Organizations

Computing and Computational Sciences Directorate

Computational Sciences and Engineering Division

Quantum Information Science Section

Quantum Communications and Networking Group
#### Nihad Owaid, Appellant, v Country-Wide Insurance Company, Respondent.

[774 NYS2d 748]

In an action to recover damages for nonpayment of medical services rendered to the defendant’s insureds, the plaintiff appeals from an order of the Supreme Court, Kings County (Partnow, J.), dated January 13, 2003, which granted the defendant’s motion to vacate a judgment of the same court (Archer, J.H.O.), dated October 7, 2002, entered upon the defendant’s default in appearing and answering.

Ordered that the order is reversed, on the law and as a matter of discretion, with costs, the motion to vacate is denied, and the judgment is reinstated.

A defendant attempting to vacate a default judgment must establish both a reasonable excuse for the default and a meritorious defense *(see Roussodimou v Zafiriadis,*238 AD2d 568 [1997]). While the determination of what constitutes a reasonable excuse for a default lies within the sound discretion of the trial court *(see Bardales v Blades,*191 AD2d 667 [1993]), *646reversal is warranted where the court improvidently exercises its discretion. The court has discretion to accept law office failure as a reasonable excuse but *“a*pattern of willful default and neglect” should not be excused *(Roussodimou v Zafiriadis, supra*at 569 [internal quotation marks omitted]).

The court improvidently exercised its discretion in granting the defendant’s motion to vacate its default. The only excuse offered, “due to a clerical error, the summons and complaint were not matched to the appropriate file” was insufficient under the circumstances of this case (see *Ortiz v Delmar Recycling Corp.,*244 AD2d 392 [1997]). Moreover, the defendant failed to present any reasonable excuse for its various other defaults in this case including the failure to appear at the inquest and the failure to take any steps to vacate the default until the city mar-shall levied an execution on its personal property. Santucci, J.P., Smith, Luciano and Adams, JJ., concur.
<PAGE>


                                                                   EXHIBIT 32.2


WRITTEN STATEMENT OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

         The undersigned, the Chief Financial Officer of S1 Corporation (the
"Company"), hereby certifies that, to his knowledge on the date hereof:

(a)      the Form 10-K Report of the Company for the year ended December 31,
         2004 filed on the date hereof with the Securities and Exchange
         Commission (the "Report") fully complies with the requirements of
         Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)      information contained in the Report fairly presents, in all material
         respects, the financial condition and results of operations of the
         Company.



                                         /S/ MATTHEW HALE
                                         --------------------------------------
                                         Matthew Hale
                                         Chief Financial Officer

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange commission or its
staff upon request.


August 25, 2005
# L_2012120DE.01001602.xml

| 5.5.2012 | DE | Amtsblatt der Europäischen Union | L 120/16 |
| --- | --- | --- | --- |

5.5.2012

DE

Amtsblatt der Europäischen Union

L 120/16

---

Berichtigung der Verordnung (EU) Nr. 1007/2011 des Europäischen Parlaments und des Rates vom 27. September 2011 über die Bezeichnungen von Textilfasern und die damit zusammenhängende Etikettierung und Kennzeichnung der Faserzusammensetzung von Textilerzeugnissen und zur Aufhebung der Richtlinie 73/44/EWG des Rates und der Richtlinien 96/73/EG und 2008/121/EG des Europäischen Parlaments und des Rates

(
  Amtsblatt der Europäischen Union L 272 vom 18. Oktober 2011
  )

Amtsblatt der Europäischen Union L 272 vom 18. Oktober 2011

Seite 13, Anhang I Tabelle 2 Nummer 26:

anstatt:

„Seide“

muss es heißen:

„Polyacryl“.

Seite 18, Anhang V Nummer 16:

anstatt:

„Leder- und Sattlerwaren, aus Spinnstoffen“

muss es heißen:

„Täschner- und Sattlerwaren, aus Spinnstoffen“.

---
EXHIBIT 32.1
 Written Statement of Chief Executive Officer Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
  (a)
    
    the Form 10-K Report of the Company for the
year ended December 31, 2008 filed on the
date hereof with the Securities and Exchange
Commission (the Report) fully complies
with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of
1934; and(b)
    
    information contained in the Report fairly
presents, in all material respects, the
financial condition and results of
operations of the Company.
 /s/ JOHANN DREYERJohann DreyerChief Executive Officer
(Principal Executive Officer)
[Federal Register Volume 89, Number 200 (Wednesday, October 16, 2024)]
[Notices]
[Page 83496]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24013]


=======================================================================
-----------------------------------------------------------------------

FEDERAL DEPOSIT INSURANCE CORPORATION


Sunshine Act Meetings

TIME AND DATE: 10:00 a.m. on October 17, 2024.

PLACE: This Board meeting will be open to public observation only by 
webcast. Visit https://www.fdic.gov/news/board-matters/video.html for a 
link to the webcast. FDIC Board Members and staff will participate from 
FDIC Headquarters, 550 17th Street NW, Washington, DC.
    Observers requiring auxiliary aids (e.g., sign language 
interpretation) for this meeting should email 
<a href="/cdn-cgi/l/email-protection#3d79544e5c5f54515449446d4f525a4f5c507d5b59545e135a524b"><span class="__cf_email__" data-cfemail="8ecae7fdefece7e2e7faf7defce1e9fcefe3cee8eae7eda0e9e1f8">[email protected]</span></a> to make necessary arrangements.

STATUS: Open to public observation via webcast.

MATTERS TO BE CONSIDERED: The Federal Deposit Insurance Corporation's 
Board of Directors will meet to consider the following matters:

Discussion Agenda

    Briefing: Semi-annual Update on the Deposit Insurance Fund (DIF) 
Restoration Plan.

Summary Agenda

    No substantive discussion of the following items is anticipated. 
The Board will resolve these matters with a single vote unless a member 
of the Board of Directors requests that an item be moved to the 
discussion agenda.
    Designated Reserve Ratio for 2025.
    Delay of Compliance Date for Subpart A Amendments to FDIC Official 
Sign and Advertising Rule.
    Minutes of a Board of Directors' Meeting Previously Distributed.
    Supplementary Information: This Sunshine Act notice is being issued 
to give notice of a revision to the title of a matter listed on the 
Sunshine Act notice previously issued regarding the October 17, 2024 
meeting. The matter titled as ``Delay of Compliance Date for [Certain] 
[Subpart A] Amendments to FDIC Official Sign and Advertising Rule'' on 
the previous notice, issued October 10, 2024, is now titled ``Delay of 
Compliance Date for Subpart A Amendments to FDIC Official Sign and 
Advertising Rule.''

CONTACT PERSON FOR MORE INFORMATION: Direct requests for further 
information concerning the meeting to Debra A. Decker, Executive 
Secretary of the Corporation, at 202-898-8748.
    Authority: 5 U.S.C. 552b

    Dated at Washington, DC, on October 11, 2024.

Federal Deposit Insurance Corporation.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2024-24013 Filed 10-11-24; 4:15 pm]
BILLING CODE 6714-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
July 30 , 2015

Mr . Christopher Thompson

Birds Eye Pix and VT

268 Canal Rd

Waterloo, SC 29384

Dear Mr . Thompson :

This letter is to inform you that we are unable to process your request for an exemption from

Title 14, Code of Federal Regu lations (14 CFR). It explains why we can not process your

request and what you should do in the next 30 days.

Why We Can No t Process Your Request

We entered your July 7 , exemption request into the public docket (No. FAA

- 20 15

- 1595 ), but

we are unable to p rocess your request any further. The information you sent does no t comply

with the requirements of § 11.81 (copy enclosed). For us to consider the request any further,

you must send us all of the following:

 The reasons why granting the request would be in the public interest; that is, how it would

benefit the public as a whole.

 Any additional information, views, or arguments available to support your request.

What You Should Do

If you want us to process your request any further, you must send the information described

earlier to reach us within 30 days. Please note that § 11.63(d) requires you to send your

petition for exemption at least 120 days before the proposed effectiv e date of the exemption.2

If We Do No t Hear From You

If we do not hear from you within 30 days, we will close the docket without notifying you

further. If you have any questions or require additional time, you may call (202) 267

- 9677.

Sincerely,

/s/

Brit tany Newton

Program Analyst, Airmen and

Airspace Rules Division

Enclosure
EXHIBIT 32.2

                  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Purden Lake Resource Corp. (the
"Company") on Form 10-Q for the period ending June 30, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Lisa
Lopomo, Principal Financial Officer of the Company, certify, pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
13th day of August, 2008.


/s/ Lisa Lopomo
------------------------------
Principal Financial Officer
# «m-/r ELECTRONIC RECORD
COA# 04-14-00025-CR OFFENSE: Murder Frances Rosalez Ford v. The 

### STYLE: stateofTexas COUNTY: Bexar AFFIRMED AS COA DISPOSITION: MODIFIED TRIAL COURT: 227TM DistrictCourt DATE:04/01/2015 Publish: NO TCCASE#: 2011CR2986



### IN THE COURT OF CRIMINALAPPEALS ELECTRONIC RECORD 

### STYLE: «Style1» v. «Style2» CCA#: 

# HH-tsr pje/9 se Petition CCA Disposition: ^J CCA IS: DATE: JUDGE: • • • wir FOR DISCRETIONARY REVIEW II 

# DATE: Oclh/'?V/J~ 

# JUDGE: faflsA**-. SIGNED: PUBLISH: PC: DNP:

MOTION FOR REHEARING IN CCA IS: JUDGE:
ex10a.htm
















Exhibit 10(a)

















Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm












We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 16 to the 1933 Act Registration Statement (Form N-4 No. 333-149449) pertaining to Lincoln New York Account N for Variable Annuities, which is incorporated by reference into Post-Effective Amendment No. 17 to the 1933 Act Registration Statement (Form N-4 No. 333-149449) and Amendment No. 286 to the 1940 Act Registration Statement (Form N-4 No. 811-09763), and to the use therein of our reports dated (a) April 1, 2014, with respect to the financial statements of Lincoln Life & Annuity Company of New York and (b) April 1, 2014, with respect to the financial statements of Lincoln New York Account N for Variable Annuities for the registration of interests in a separate account under individual flexible payment deferred variable annuity contracts.







/s/ Ernst & Young LLP
















Philadelphia, Pennsylvania


August 22, 2014
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

          - [Disaster Declaration #20732 and #20733; FLORIDA Disaster Number FL-20014]

# AGENCY:

U.S. Small Business Administration.

# ACTION:

Amendment 2.

# SUMMARY:

This is an amendment of the Presidential declaration of a major disaster for Public Assistance Only for the State of Florida (FEMA-4828-DR), dated 10/05/2024.

*Incident:*                         Hurricane Helene.                    

*Incident Period:*                         09/23/2024 and continuing.                    

# DATES:

Issued on 10/13/2024.

*Physical Loan Application Deadline Date:*                         12/04/2024.                    

*Economic Injury (EIDL) Loan Application Deadline Date:*                         07/07/2025.                    

# ADDRESSES:

*Visit the MySBA Loan Portal at https://lending.sba.gov*                         to apply for a disaster assistance loan.                    

# FOR FURTHER INFORMATION CONTACT:

Alan Escobar, Office of Disaster Recovery & Resilience, U.S. Small Business Administration, 409 3rd Street SW, Suite 6050, Washington, DC 20416, (202) 205-6734.

# SUPPLEMENTARY INFORMATION:

The notice of the President's major disaster declaration for Private Non-Profit organizations in the State of Florida, dated 10/05/2024, is hereby amended to include the following areas as adversely affected by the disaster.

*Primary Counties:*                     Baker, Nassau, Putnam.                

All other information in the original declaration remains unchanged.

(Catalog of Federal Domestic Assistance Number 59008)

Rafaela Monchek

Deputy Associate Administrator, Office of Disaster Recovery & Resilience.

[FR Doc. 2024-24175 Filed 10-17-24; 8:45 am]

BILLING CODE 8026-09-P
### SAT Report PMN Number: P-13-0864 SAT Date: 9/10/2013 Print Date: 6/4/2014

Related cases :

Concern levels : Type of Concern: Health Eco Comments Level of Concern: 2-3 3

Persistence Bioaccum Toxicity Comments 1 1 2 PMN 1 1 2 Hyd Pdt

Exposure Based Review : Health: N o Ecotox: Yes
Routes of exposure : Health: Dermal Drinking Water Inhalation Ecotox: All releases to water Fate: ; Hyd Pdt moderate
Keywords : Keywords: SEVER IRR/POSS CORR E,S,L SENS-S,L N EURO UNCERT INH ONCO AQUATOX-A,C
Summary of Assessment :

Fate : Fate Summary: P-13-0864 FATE: Estimations for hydrolysis product MW 290 log Kow = 4.59 (E) log Koc = 3.10 (E) log Fish BCF = 2.70 (E) log Fish BAF = 2.79 (E)PMN Substance: Liquid with MP < 25 C (E) S = Reacts Hydrolysis Half-life ≤ min VP = 2.8E-5 torr at 25 C (E) BP = 378 C (E) H < 1.00E-8 (E) POTW removal (%) = PMN 99 via hydrolysis; then Hyd Pdt 60-90 via sorption and biodeg Time for complete ultimate aerobic biodeg = Hyd Pdt wk-mo Sorption to soils/sediments = Hyd Pdt moderate PBT Potential: PMN P1B1; Hyd Pdt P1B1 *CEB FATE: Migration to ground water = Hyd Pdt moderate

Health : Health Summary: Absorption of the neat material is nil through the skin, while absorption is poor with reaction through the skin for the material in solution, and poor with reaction through the lung and GI tract, based on physical/chemical properties. There is concern for severe irritation/ p ossible corrosion to the eye, skin, and lung, based on reactivity. There are also concerns for neurotoxicity, dermal and respiratory sensitization, and inhalation oncogenicity, based on analogs and potentials.

Ecotox :
Test Organism Test Type Test End Point Predicted Measured Comments

fish 96-h LC50 1.2 daphnid 48-h LC50 1.9 green algal 96-h EC50 0.53 fish

_ chronic value 0.052 daphnid

_ chronic value 0.61

algal

_ chronic value 0.32

Sewage Sludge 3-h EC50

_ Sewage Sludge

_ Chronic Value _

Ecotox Values Comments: Predictions are based on SARs for esters; SAR chemical class = ester MW 309; log Kow = 4.59 (EPI, hydrolysis product); liquid with mp unknown (P); S = reacts rapidly with water at 25 C (P); p H7; effective concentrations based on 100% active ingredients and mean measured concentrations; hardness <150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments Assessment Factor 10 Concentration of Concern 5( p pb) SARs esters SAR Class esterEcotox Category Esters

Ecotox Factors Comments:

SAT Chair: J. Kwiat